TY - JOUR
T1 - Group II metabotropic glutamate receptor modulation of excitatory transmission in rat subthalamic nucleus
AU - Shen, Ke Zhong
AU - Johnson, Steven W.
PY - 2003/12/1
Y1 - 2003/12/1
N2 - Patch pipettes were used to record currents in whole-cell configuration to study the effects of group II metabotropic glutamate receptor (mGluR) stimulation on synaptic transmission in slices of at subthalamic nucleus. Evoked glutamatergic excitatory postsynaptic currents (EPSCs) were reversibly reduced by the selective group II mGluR agonist (2′S,2′R,3′R)-2-(2′,3′ -dicarboxycyclopropyl)glycine (DCG IV) in a concentration-dependent manner, with an IC50 of 0.19 ± 0.05 μM. DCG IV (1 μM) had no effect on inhibitory postsynaptic currents mediated by GABA. DCG IV-induced inhibition of EPSCs was reversed by the selective group II mGluR antagonist LY 341495 (100 nM) and mimicked by another selective group II agonist (2S,1′S,2′S)-2-(carboxycyclopropyl)glycine (L-CCG-I). Inhibition of EPSC amplitude by DCG IV and L-CCG-I was associated with an increase in the paired-pulse ratio of EPSCs. The protein kinase C (PKC) activator phorbol 12-myristate 13-acetate (2 μM) reduced the inhibitory effect of DCG IV on EPSCs. However, the response to DCG IV was not affected by the protein kinase A (PKA) activator forskolin (20 μM), by the adenylyl cyclase inhibitor MDL 12230A (20,μM), or by the phosphodiesterase inhibitor Ro 20-1724 (50 μM). DCG IV-induced inhibition of EPSCs was reduced by the non-selective protein kinase inhibitors H-7 (100 μM), H-8 (50 μM) and HA-1004 (100 μM). These results suggest that group II mGluR stimulation acts presynaptically to inhibit glutamate release by a PKC-dependent mechanism in the subthalamic nucleus.
AB - Patch pipettes were used to record currents in whole-cell configuration to study the effects of group II metabotropic glutamate receptor (mGluR) stimulation on synaptic transmission in slices of at subthalamic nucleus. Evoked glutamatergic excitatory postsynaptic currents (EPSCs) were reversibly reduced by the selective group II mGluR agonist (2′S,2′R,3′R)-2-(2′,3′ -dicarboxycyclopropyl)glycine (DCG IV) in a concentration-dependent manner, with an IC50 of 0.19 ± 0.05 μM. DCG IV (1 μM) had no effect on inhibitory postsynaptic currents mediated by GABA. DCG IV-induced inhibition of EPSCs was reversed by the selective group II mGluR antagonist LY 341495 (100 nM) and mimicked by another selective group II agonist (2S,1′S,2′S)-2-(carboxycyclopropyl)glycine (L-CCG-I). Inhibition of EPSC amplitude by DCG IV and L-CCG-I was associated with an increase in the paired-pulse ratio of EPSCs. The protein kinase C (PKC) activator phorbol 12-myristate 13-acetate (2 μM) reduced the inhibitory effect of DCG IV on EPSCs. However, the response to DCG IV was not affected by the protein kinase A (PKA) activator forskolin (20 μM), by the adenylyl cyclase inhibitor MDL 12230A (20,μM), or by the phosphodiesterase inhibitor Ro 20-1724 (50 μM). DCG IV-induced inhibition of EPSCs was reduced by the non-selective protein kinase inhibitors H-7 (100 μM), H-8 (50 μM) and HA-1004 (100 μM). These results suggest that group II mGluR stimulation acts presynaptically to inhibit glutamate release by a PKC-dependent mechanism in the subthalamic nucleus.
UR - http://www.scopus.com/inward/record.url?scp=0348042158&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0348042158&partnerID=8YFLogxK
U2 - 10.1113/jphysiol.2003.052209
DO - 10.1113/jphysiol.2003.052209
M3 - Article
C2 - 14500768
AN - SCOPUS:0348042158
SN - 0022-3751
VL - 553
SP - 489
EP - 496
JO - Journal of Physiology
JF - Journal of Physiology
IS - 2
ER -